Release Date: 11/08/16 10:04 Summary: Appendix 4G and Corporate Governance Statement-ONT.AX Price Sensitive: No Download Document 873.38KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%